The Toronto-Dominion Bank
TD
Canadian Imperial Bank of Commerce
CM
Royal Bank of Canada
RY
Bank of Nova Scotia
BNS
Bank of Montreal
BMO
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.